Trial Profile

Phase II Study of High Dose Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation.

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amikacin; Amikacin
Indications Bacterial infections; Pneumonia
Focus Pharmacokinetics
Acronyms DARTAGNAN; Dartagnan3

Most Recent Events

04 Jul 2012 Merck and Co added as associations as reported in the European Clinical Trials Database record.
07 Nov 2011 Additional trial acronym Dartagnan3 identified as reported by ClinicalTrials.gov.
07 Nov 2011 Actual initiation date (Aug 2008) added as reported by European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com